ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils

Psoriasis is a common inflammatory skin disease resulting from an interplay of keratinocytes and immune cells. Previous studies have identified an essential role of autophagy in the maintenance of epidermal homeostasis including proliferation and differentiation. However, much less is known about th...

Full description

Bibliographic Details
Main Authors: Xiaonan Qiu, Lin Zheng, Xiuting Liu, Dan Hong, Mintong He, Zengqi Tang, Cuicui Tian, Guozhen Tan, Sam Hwang, Zhenrui Shi, Liangchun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.714274/full
_version_ 1819128737755561984
author Xiaonan Qiu
Lin Zheng
Lin Zheng
Xiuting Liu
Dan Hong
Mintong He
Zengqi Tang
Cuicui Tian
Guozhen Tan
Sam Hwang
Zhenrui Shi
Liangchun Wang
author_facet Xiaonan Qiu
Lin Zheng
Lin Zheng
Xiuting Liu
Dan Hong
Mintong He
Zengqi Tang
Cuicui Tian
Guozhen Tan
Sam Hwang
Zhenrui Shi
Liangchun Wang
author_sort Xiaonan Qiu
collection DOAJ
description Psoriasis is a common inflammatory skin disease resulting from an interplay of keratinocytes and immune cells. Previous studies have identified an essential role of autophagy in the maintenance of epidermal homeostasis including proliferation and differentiation. However, much less is known about the role of autophagy-related proteins in the cutaneous immune response. Herein, we showed that ULK1, the key autophagic initiator, and its phosphorylation at Ser556 were distinctively decreased in the epidermis from lesional skin of psoriasis patients. Topical application of SBI0206965, a selective ULK1 inhibitor, significantly attenuated epidermal hyperplasia, infiltration of neutrophils, and transcripts of the psoriasis-related markers in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD). In vitro, ULK1 impairment by siRNA and SBI0206965 arrested cell proliferation and promoted apoptosis of keratinocytes but had a marginal effect on the expression of proinflammatory mediators under steady status. Surprisingly, SBI0206965 blocked the production of chemokines and cytokines in keratinocytes stimulated by neutrophils. Of interest, the pro-apoptotic and anti-inflammatory effects of ULK1 inhibition cannot be fully replicated by autophagic inhibitors. Our findings suggest a self-regulatory process by downregulating ULK1 to maintain the immune homeostasis of psoriatic skin via regulating keratinocytes and their crosstalk with neutrophils, possibly through both autophagy-dependent and independent mechanisms. ULK1 might be a potential target for preventing or treating psoriasis.
first_indexed 2024-12-22T08:32:35Z
format Article
id doaj.art-f580f3b65fe640c885d51146fa3fbd21
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T08:32:35Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-f580f3b65fe640c885d51146fa3fbd212022-12-21T18:32:28ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-08-011210.3389/fimmu.2021.714274714274ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With NeutrophilsXiaonan Qiu0Lin Zheng1Lin Zheng2Xiuting Liu3Dan Hong4Mintong He5Zengqi Tang6Cuicui Tian7Guozhen Tan8Sam Hwang9Zhenrui Shi10Liangchun Wang11Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaInstitute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, University of California, Davis, Sacramento, CA, United StatesDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaPsoriasis is a common inflammatory skin disease resulting from an interplay of keratinocytes and immune cells. Previous studies have identified an essential role of autophagy in the maintenance of epidermal homeostasis including proliferation and differentiation. However, much less is known about the role of autophagy-related proteins in the cutaneous immune response. Herein, we showed that ULK1, the key autophagic initiator, and its phosphorylation at Ser556 were distinctively decreased in the epidermis from lesional skin of psoriasis patients. Topical application of SBI0206965, a selective ULK1 inhibitor, significantly attenuated epidermal hyperplasia, infiltration of neutrophils, and transcripts of the psoriasis-related markers in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD). In vitro, ULK1 impairment by siRNA and SBI0206965 arrested cell proliferation and promoted apoptosis of keratinocytes but had a marginal effect on the expression of proinflammatory mediators under steady status. Surprisingly, SBI0206965 blocked the production of chemokines and cytokines in keratinocytes stimulated by neutrophils. Of interest, the pro-apoptotic and anti-inflammatory effects of ULK1 inhibition cannot be fully replicated by autophagic inhibitors. Our findings suggest a self-regulatory process by downregulating ULK1 to maintain the immune homeostasis of psoriatic skin via regulating keratinocytes and their crosstalk with neutrophils, possibly through both autophagy-dependent and independent mechanisms. ULK1 might be a potential target for preventing or treating psoriasis.https://www.frontiersin.org/articles/10.3389/fimmu.2021.714274/fullULK1 (unc-51 like autophagy activating kinase 1)psoriasiskeratinocyteneutrophilautophagy
spellingShingle Xiaonan Qiu
Lin Zheng
Lin Zheng
Xiuting Liu
Dan Hong
Mintong He
Zengqi Tang
Cuicui Tian
Guozhen Tan
Sam Hwang
Zhenrui Shi
Liangchun Wang
ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
Frontiers in Immunology
ULK1 (unc-51 like autophagy activating kinase 1)
psoriasis
keratinocyte
neutrophil
autophagy
title ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
title_full ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
title_fullStr ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
title_full_unstemmed ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
title_short ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
title_sort ulk1 inhibition as a targeted therapeutic strategy for psoriasis by regulating keratinocytes and their crosstalk with neutrophils
topic ULK1 (unc-51 like autophagy activating kinase 1)
psoriasis
keratinocyte
neutrophil
autophagy
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.714274/full
work_keys_str_mv AT xiaonanqiu ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT linzheng ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT linzheng ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT xiutingliu ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT danhong ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT mintonghe ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT zengqitang ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT cuicuitian ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT guozhentan ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT samhwang ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT zhenruishi ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils
AT liangchunwang ulk1inhibitionasatargetedtherapeuticstrategyforpsoriasisbyregulatingkeratinocytesandtheircrosstalkwithneutrophils